A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia

Archives of Internal Medicine

Volumn 161, Issue 12, 2001, Pages 1529-1533

  Smego R A , Jr ^a   Nagar, S ^a   Maloba, B ^a   Popara, M ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; EFLORNITHINE; PENTAMIDINE; PRIMAQUINE; TRIMETREXATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; META ANALYSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0034918710     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.12.1529     Document Type: Article

References (50)

1. Prevention and treatment of Pneumocystis pneumonia
2. Trimethoprim-sulfamethoxazole vs pentamidine for Pneumocystis carinii pneumonia in AIDS patients: Results of a large prospective randomized treatment trial
3. Treatment of infection due to Pneumocystis carinii
4. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients
5. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome
6. Treatment for Pneumocystis carinii pneumonia
7. Comparison of trimethoprimsulfamethoxazole (TMP-SMZ) and pentamidine (PNT) in the treatment of Pneumocystis carinii pneumonia (PCP)
8. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia
9. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia
10. Failure of trimethoprimsulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia
11. An outbreak of Pneumocystis carinii pneumonia in homosexual men
12. Pneumocystis carinii pneumonia treated with α-difluoromethylornithine
13. Treatment of Pneumocystis carinii pneumonitis
14. Pulmonary complications of the acquired immunodeficiency syndrome - An update: Report of the Second National Heart, Lung, and Blood Institute Workshop
15. Assessment of therapy for Pneumocystis carinii pneumonia
16. The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
17. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
18. Aerosolized pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immune deficiency syndrome
19. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with AIDS
20. Cyclosporine therapy and refractory Pneumocystis carinii pneumonia
21. Pentamidine treatment of Pneumocystis carinii pneumonia in AIDS
22. Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
23. Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: A different perspective
24. Clindamycin with primaquine for Pneumocystis carinii pneumonia
25. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A controlled trial of trimethoprim-sulfamethoxazole vs trimethoprim-dapsone
26. Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS: A randomized trial
27. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS
28. Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy
29. Trimetrexate (TMTX) salvage therapy for PCP in AIDS patients with limited therapeutic options
30. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia
31. Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with AIDS
32. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS
33. Trimetrexate-leukovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia
34. Trimetrexate with leukovorin versus trimethoprim-sulfamethoxazole for moderate-to-severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: A prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031
35. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS
36. Atovaquone for Pneumocystis carinii pneumonia
37. A preliminary evaluation of 566C80 for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
38. Clindamycin/primaquine for Pneumocystis carinii pneumonia
39. Efficacy of clindamycin/primaquine versus trimethoprimsulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia
40. Clindamycin/primaquine for treatment of Pneumocystis carinii pneumonia in patients with AIDS
41. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: A randomized, double-blind pilot trial
42. Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS
43. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044
44. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS: A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsonetrimethoprim, and clindamycin-primaquine
45. Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: A multicenter, double-blind, randomized trial (CTN 004)
46. Spectrum of pulmonary disease associated with the acquired immune deficiency syndrome
47. Respiratory disease in the immunosuppressed patient
48. Pulmonary manifestations of acquired immunodeficiency syndrome
49. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients
50. Dual pulmonary infection with Mycobacterium tuberculosis and Pneumocystis carinii in HIV-infected patients